Patients with impaired renal function: there is no significant difference in pharmacokinetic parameters between patients with moderate or severe chronic renal insufficiency (creatinine clearance between 10 and 50 ml. min-1) and healthy volunteers after a single oral dose of 50 mg riluzole.